BCIQ Profiles

Company Profile Report

Celenex takeout first of several expected Amicus gene therapy deals

Just weeks after gaining its first FDA approval, Amicus Therapeutics Inc. (NASDAQ:FOLD) has announced its entrance into the gene therapy space with the acquisition of Nationwide Children's Hospital spinout Celenex (Columbus, Ohio) for $100 million in cash up front, plus

Read the full 402 word article

How to gain access

Continue reading with a
two-week free trial.